Genetic testing in families with hereditary nonpolyposis colon cancer

JAMA

Volumn 281, Issue 17, 1999, Pages 1618-1622

  Lerman, Carya ^a   Hughes, Chanita ^a   Trock, Bruce J ^a   Myers, Ronald E ^c   Main, David ^a   Bonney, Aba ^a   Abbaszadegan, Mohammad R ^b   Harty, Anne E ^d   Franklin, Barbara A ^d   Lynch, Jane F ^d   Lynch, Henry T ^d  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DEPRESSION; FAMILIAL CANCER; FAMILY STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033526342     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.17.1618     Document Type: Article

References (34)

1. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 1993;104:1535-1549.
2. Peltomäki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science. 1993;260:810-812.
3. Lindblom A, Tannergard P, Werelius B, Nordenskjold M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet. 1993;5:279-282.
4. Nystrom-Lahti M, Parsons R, Sistonen P, et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet. 1994;55:659-665.
5. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 1994;371:75-80.
6. Lynch HT, Smyrk T, Lynch J. An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet 1997;93: 84-99.
7. Lynch HT, Smyrk T. An update of Lynch syndrome (HNPCC). Curr Opin Oncol. 1998;10:349-356.
8. Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 1995;108:1405-1411.
9. Vasen HF, van Ballegooijen M, Buskens E, et al. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer. 1998;82:1632-1637.
10. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998;338:1481-1487.
11. Croyle RT, Lerman C. Interest in genetic testing and colon cancer susceptibility: cognitive and emotional correlates. Prev Med. 1993;22:284-292.
12. Lerman C, Marshall J, Audrain J, Gomez-Caminero A. Genetic testing for colon cancer susceptibility. Int J Cancer. 1996;69:58-61.
13. Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. JAMA. 1996;275:1885-1892.
14. Watson M, Lloyd SM, Eeles R, et al. Psychosocial impact of testing (by linkage) for the BRCA1 breast cancer gene. Psychooncology. 1996;5:233-239.
15. Lerman C, Schwartz M, Lin TH, et al. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol. 1997;65:414-420.
16. Lerman C, Daly M, Sands C, et al. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst. 1993;85:1074-1080.
17. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:1406-1422.
18. Myers RE, Ross E, Jepson C, et al. Modeling adherence to colorectal cancer screening. Prev Med. 1994;23:142-151.
19. Radloff LS. The CES-D Scale. Appl Psychol Meas. 1977;1:385-401.
20. Horowitz M, Wilner N, Alvarez W. Impact of Events Scale. Psychosom Med. 1979;41:209-218.
21. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986; 42:121-130.
22. Blalock SJ, De Vellis BM, Sandler RS. Participation in fecal occult blood screening: a critical review. Prev Med. 1987;16:9-18.
23. Kunkel EJ, Woods CM, Rodgers C, Myers RE. Consultations for "maladaptive denial of illness" in patients with cancer. Psychooncology. 1997;6:139-149.
24. Radloff LS. Sex differences in depression. Sex Roles. 1975;1:249-265.
25. Pearlin LI, Schooler C. The structure of coping. J Health Soc Behav. 1978;19:2-21.
26. Belle D. The stress of caring: women as providers of social support. In: Goldberger L, Breznitz S, eds. Handbook of Stress: Theoretical and Clinical Aspects. New York, NY: Free Press; 1982:496-505.
27. Kessler RC, McLeod JD. Sex differences in vulnerability to network events. Am Sociol Rev. 1984; 49:620-631.
28. Pearlin LI. Sex roles and depression. In: Datan N, Ginsberg LH, eds. Life Span Developmental Psychology: Normative Life Crises. New York, NY: Academic Press; 1975:191-207.
29. Pearlin LI, Lieberman MA. Social sources of emotional distress. In: Simmons R, ed. Research in Community and Mental Health. Greenwich, Conn: JAI Press; 1979:217-248.
30. Anderson LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health. 1995;85:840-842.
31. Brown ML, Potosky AL, Thompson GB, Kessler LG. The knowledge and use of screening test for colorectal and prostate cancer. Prev Med. 1990;19:562-574.
32. Centers for Disease Control and Prevention. Screening for colorectal cancer - United States, 1992-1993. JAMA. 1996;275:830-831.
33. Lerman C, Lustbader E, Rimer B, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst. 1995;87:286-292.
34. Vernon SW, Gritz ER, Peterson SK, et al. Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol. 1997;16:73-86.